Let's find what you are looking for

Agility Clinical now Precision For Medicine Inc. provides contract research and consultancy services oncology and rare disease. Precision’s uniquely integrated offering enables the science of precision medicine by combining novel clinical trial designs, industry-leading operational and medical experts, advanced biomarker solutions, and an unequivocal passion for rare diseases and oncology. The result: a tailored pathway to approval for oncology and rare disease innovators.

CMIC Group pioneered the CRO business in Japan over 28 years ago. Since then, CMIC has continued as a leading innovator in the industry and has expanded services to encompass the entire pharmaceutical value-chain. We pride ourselves on meeting customers where they are and with exactly what they need to move their products forward.

Clintec, established for 22 years, is an innovative, medium-sized global functional services provider with a depth of expertise in oncology and rare diseases. Clintec combines the agility and flexibility typical of smaller CROs with the global coverage associated with large CROs. Clintec delivers global projects with speed, efficiency, and cost-effectiveness. Clintec personnel are based in over 50 countries including several differentiated emerging markets, such as in Sub-Saharan Africa.

Clinica Group is the first active CRO in Algeria, created in 2007 and approved by the Algerian Ministry of Health.

The international training of our team (in Europe and the USA) coupled with our experience in the management of interventional, observational and pharmaco-epidemiological clinical studies in different therapeutic areas, allows us to meet the different needs of our customers, putting their satisfaction at the center of our concerns.

Our employees work in compliance with international standards (Declaration of Helsinki, ICH-GCP ...) to meet the expectations of our pharmaceutical and institutional partners.

ComplianceLogix is a Contract Quality Organization (CQO) that provides effective regulatory compliance training and quality assurance consulting services. Our industry experienced consultants provide complete Quality Assurance support including GCP, GLP and GMP training, vendor audits, clinical investigator audits, batch record review, SOP writing, and quality systems implementation.

Our clients include industry leading biotechnology, pharmaceutical, medical device and international non-profit organizations developing innovative and life-saving therapeutics.

It is Collage of American Pathologist (CAP) accredited laboratory and world’s leading network of clinical research central laboratory to access a wide range of comprehensive solutions. From standard testing to customized assays, you’ll receive globally consistent, actionable data to drive your studies forward—faster.

Covance, a global contract research organization, worked on all of the top 50 best-selling drugs available today through its full spectrum of nonclinical, clinical and commercialization services.

yrdy

George Clinical is a leading contract research organization (CRO), headquartered in Sydney, Australia, with approximately 300 people providing the full range of clinical trial services to pharmaceutical, medical device and diagnostic customers, for all trial phases, registration and post-marketing trials. George Clinical combines scientific and clinical leadership with expert trial delivery to create distinctive world-class solutions.

ICON was the first global CRO to establish operations in the region and today is one of the largest. We are six countries (Argentina, Brazil, Chile, Colombia, Mexico and Peru), providing in-depth experience, and local expertise, on what is required to contribute to global and regional study delivery.

ICON was the first global CRO to establish operations in the region and today is one of the largest. We are six countries (Argentina, Brazil, Chile, Colombia, Mexico and Peru), providing in-depth experience, and local expertise, on what is required to contribute to global and regional study delivery.

Our mission is to help clients accelerate the development of drugs and devices that save lives and improve quality of life.

Novotech has been instrumental in the success of hundreds of Phase I - IV clinical trials in the Asia Pacific Region. Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services, central lab services, report write-up to ICH requirements, project and vendor management. Novotech’s strong Asia Pacific presence includes running clinical trials in all key regional markets. Novotech also has worldwide reach through the company's network of strategic partners.

As a recognized leader in conducting complex, global oncology and hematology trials, PRA has contributed expert services critical to the approval of 16 important drugs. We have more than 5,000 team members providing service coverage across 38 European countries, and we’ve also developed a strategic CRO partnership to provide coverage in Estonia, Latvia, and Lithuania. Services included: Clinical Development, Clinical Diagnostics and Site Commercial Solutions.

Our strong regional presence and coverage for staffing, operations, and investigator relationships across Europe has won us numerous awards in the CRO industry, including PharmaTimes’ “International Clinical Company of the Year—Europe and APAC” for six years and counting.

As a recognized leader in conducting complex, global oncology and hematology trials, PRA has contributed expert services critical to the approval of 16 important drugs. We have more than 5,000 team members providing service coverage across 38 European countries, and we’ve also developed a strategic CRO partnership to provide coverage in Estonia, Latvia, and Lithuania. Services included: Clinical Development, Clinical Diagnostics and Site Commercial Solutions.

Our strong regional presence and coverage for staffing, operations, and investigator relationships across Europe has won us numerous awards in the CRO industry, including PharmaTimes’ “International Clinical Company of the Year—Europe and APAC” for six years and counting.

As a recognized leader in conducting complex, global oncology and hematology trials, PRA has contributed expert services critical to the approval of 16 important drugs. We have more than 5,000 team members providing service coverage across 38 European countries, and we’ve also developed a strategic CRO partnership to provide coverage in Estonia, Latvia, and Lithuania. Services included: Clinical Development, Clinical Diagnostics and Site Commercial Solutions.

Our strong regional presence and coverage for staffing, operations, and investigator relationships across Europe has won us numerous awards in the CRO industry, including PharmaTimes’ “International Clinical Company of the Year—Europe and APAC” for six years and counting.

PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our customers include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and approximately 23,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.

We are offering strategic combination of industry acumen, global compliance and therapeutic expertise to help ensure that your innovation ideas are not hindered by limited resources. Capabilities included: Strategic Product Development, Clinical Research and Development, Therapeutic and Special Population Expertise and ePremier Technology Platform.

PsychoGenics is a Preclinical CRO with expertise in the CNS and orphan disorders. The Company’s capabilities include behavioral testing, electrophysiology, translational EEG, quantitative histology, molecular biology, and microdialysis. Complementing its extensive capabilities, PsychoGenics offers a variety of validated mouse models including in-licensed transgenic models that support research in areas such as Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, Autism spectrum disorders, psychosis/schizophrenia, Spinal Muscular Atrophy (SMA), muscular dystrophy and other muscle disorders.

We are a Canadian oncology CRO with a singular focus on oncology. We play a vital role in improving the speed and efficiency of oncology clinical research through a deep understanding of the needs of sponsors, investigators and patients.
Our mission is to improve site selection and patient recruitment, and speed up clinical trials by attracting cutting-edge oncology compounds and clinical trials to Canada. The Reverse Feasibility Program is designed to connect small and mid-sized biopharma companies with a network of highly motivated investigators and their patients.